About
Cadenza Bio develops novel small-molecule oral drugs targeting demyelinating and inflammatory diseases to halt disease progression, promote repair, and improve patient quality of life.
Explore Cadenza Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.